Rheum officinale and euphorbia kansui preparation and application thereof in preparation of medicine for treating TgAb injury of human thyroid follicular cells
Through the preparation of traditional Chinese medicine composition composed of rhubarb, Gansui and donkey-hide gelatin, the problem of thyroid follicle cell damage in Hashimoto's thyroiditis is solved, and the overexpression of proliferation inhibition, apoptosis and inflammatory factors are alleviated, tissue repair is promoted, and bridge is provided. Effective treatment options for this thyroiditis.
Patent Information
- Application Number
- CN202411075266.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-22
AI Technical Summary
The existing technology cannot effectively alleviate the damage of thyroid follicular cells in Hashimoto's thyroiditis, such as proliferation inhibition, apoptosis, cell migration and inflammatory factors overexpression, and the efficacy of traditional Chinese medicine prescriptions is insufficient, and Western medicine treatment has adverse drug reactions and high cost. question.
The traditional Chinese medicine composition composed of rhubarb, Gansui and donkey-hide gelatin is prepared by soaking, decoction, concentration, freeze-drying and other steps to relieve the damage of thyroid follicle cells induced by TgAb. The preferred component ratio is 10- 18 parts rhubarb, 1-7 parts Gansui, 10-15 parts donkey-hide gelatin.
This composition can significantly alleviate the TgAb-induced thyroid follicular cell proliferation inhibition, apoptosis, cell migration and inflammatory factor overexpression damage, accelerate inflammation regression, facilitate tissue repair, reduce scratch healing rate, regulate T4 secretion level, and provide a bridge Effective basis for the treatment of this thyroiditis.
Smart Images

Figure CN118987084A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medicines, and in particular to a rhubarb and kansui preparation and application thereof in preparing a medicine for treating TgAb-damaged human thyroid follicular cells. Background Art
[0002] Hashimoto thyroiditis (HT) is an autoimmune thyroid disease with individual genetic susceptibility and environmental factors. Its pathological characteristics are mainly a large number of lymphocyte infiltration in the thyroid tissue. In the late stage, thyroid gland atrophy and even loss of thyroid function can be seen. Thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb) are the main thyroid autoantibodies against thyroglobulin (Tg) and thyroid peroxidase (TPO) antigens, respectively. High titers of TgAb and TPOAb in serum detection are the standard basis for clinical diagnosis of HT.
[0003] From the perspective of traditional Chinese medicine, Hashimoto's thyroiditis is caused by emotional disharmony, improper diet and water and soil, resulting in qi stagnation, phlegm coagulation, and blood stasis in the front of the neck as the basic pathogenesis, and the main clinical features are the lumps and swellings on both sides of the Adam's apple in the front of the neck. The key to treating HT is to control inflammation. However, Western medicine has no treatment for the cause of this disease. In the early stage of clinical plans, most of them advocate the use of Western medicine such as antithyroid drugs and glucocorticoids. Those who cannot adhere to medication can be treated with artificial radionuclide I-131. In the middle and late stages, surgical treatment such as laparoscopic thyroid surgery is usually adopted. However, there are problems such as adverse drug reactions, liver damage easily caused by achieving control effects, and slightly higher costs for laparoscopic thyroid surgery. In terms of the diagnosis and treatment of clinical diseases, traditional Chinese medicine has definite efficacy, few toxic and side effects, and is easily accepted by patients. Despite this, traditional Chinese medicine still has realistic problems such as too many syndrome differentiations and differences in compatibility and prescription composition, and cannot provide a universal basis for guiding the use of drugs in clinical HT.
[0004] Based on the above, it is very necessary to obtain a drug that can effectively relieve inflammatory damage and treat Hashimoto's thyroiditis. Summary of the invention
[0005] The purpose of the present invention is to provide a rhubarb and kansui preparation and its application in the preparation of a drug for treating TgAb-damaged human thyroid follicular cells. The rhubarb and kansui preparation obtained by formulating the raw material components of the present invention can be used to alleviate TgAb-induced damage to human thyroid follicular cells, such as proliferation inhibition, apoptosis, cell migration and overexpression of inflammatory factors, and provides a new idea for the later treatment of Hashimoto's thyroiditis.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] The invention provides a traditional Chinese medicine composition, comprising the following components in parts by weight: 10-18 parts of rhubarb, 1-7 parts of kansui and 10-15 parts of donkey-hide gelatin.
[0008] The present invention provides a method for preparing the Chinese medicine composition, comprising the following steps:
[0009] (1) adding water to the traditional Chinese medicine composition at a mass volume ratio of 1 g: (15-25) mL for soaking, then decocting and concentrating to obtain a medicinal solution;
[0010] (2) The drug solution is centrifuged, freeze-dried, and then pulverized to obtain drug powder.
[0011] Preferably, the soaking time in step (1) is 20-40 minutes.
[0012] Preferably, the decoction time is 45-70 min / time, and the decoction frequency is 2-3 times.
[0013] Preferably, the centrifugation time in step (2) is 15-30 min, and the centrifugation speed is 2000-4000 rpm.
[0014] The invention also provides a rhubarb and kansui preparation comprising the traditional Chinese medicine composition.
[0015] Preferably, the preparation is a liquid preparation.
[0016] The present invention also provides the use of the rhubarb and kansui preparation in preparing a medicine for treating TgAb-damaged human thyroid follicular cells.
[0017] Preferably, the Rhubarb and Kansui preparation is used at a concentration of 300-600 μg / mL.
[0018] By adopting the above technical solution, the present invention has the following beneficial effects:
[0019] The composition obtained by scientifically matching the three components of rhubarb, kansui and donkey-hide gelatin selected by the present invention can alleviate TgAb-induced damage to human thyroid follicular cell proliferation inhibition, apoptosis, cell migration and overexpression of inflammatory factors. The experimental results show that the Chinese medicine composition can alleviate TgAb-induced proliferation damage to thyroid follicular cells; it can alleviate the migration of damaged thyroid follicular cells, accelerate the disappearance of inflammation, and facilitate the development of tissue regeneration and repair; it can also significantly reduce the healing rate of scratches; it can also significantly alleviate the inflammatory damage of overexpression of inflammatory factor IL-6 in the thyroid follicular cell injury model, and regulate the secretion level of T4. This also provides a certain basis for the treatment of Hashimoto's thyroiditis. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1The dose-effect relationship diagram of the protective effect of rhubarb and kansui preparation on normal cells and cell injury models ( Figure 1 A is the protection rate for normal cells, and B is the protection rate for cell damage model);
[0021] Figure 2 The results of migration ability of thyroid follicular cell injury model in different groups;
[0022] Figure 3 The migration ability of thyroid follicular cells in different groups ( Figure 3 A is the cell migration of the model control group at 0 h, B is the cell migration of the model control group at 24 h, C is the cell migration of the model medication group at 0 h, and D is the cell migration of the model medication group at 24 h);
[0023] Figure 4 The morphological changes of thyroid follicular cells in different groups under an inverted phase contrast microscope ( Figure 4 A is the blank control group, B is the model control group, C is the blank treatment group, and D is the model treatment group);
[0024] Figure 5 The apoptosis of thyroid follicular cells in different groups;
[0025] Figure 6 The contents of T4 and IL-6 in thyroid follicular cells of different groups ( Figure 6 A is T4 content, B is IL-6 content). DETAILED DESCRIPTION
[0026] The invention provides a traditional Chinese medicine composition, the components of which include rhubarb, kansui and donkey-hide gelatin.
[0027] In the present invention, rhubarb is bitter and cold in nature, and has the effects of attacking and removing blood stasis, promoting blood circulation and promoting bile secretion, and anti-inflammatory, so that blood stasis can be removed by itself; gansui is bitter and cold in nature, and can clear away heat and detoxify, reduce swelling and disperse knots. The two medicines are used together to attack and remove the knots of water and blood and have anti-inflammatory effects; donkey-hide gelatin is used to prevent the strong drugs from attacking too much, and remove the evil without hurting the body.
[0028] In the present invention, the weight proportion of the rhubarb is preferably 10-18 parts, further preferably 12-16 parts, and further preferably 14 parts; the weight proportion of the kansui is preferably 1-7 parts, further preferably 2-6 parts, and further preferably 4 parts; the weight proportion of the donkey-hide gelatin is preferably 10-15 parts, further preferably 11-13.5 parts, and further preferably 12 parts.
[0029] The present invention also provides a method for preparing the Chinese medicine composition, comprising the following steps:
[0030] (1) adding water to the traditional Chinese medicine composition at a mass volume ratio of 1 g: (15-25) mL for soaking, then decocting and concentrating to obtain a medicinal solution;
[0031] (2) The drug solution is centrifuged, freeze-dried, and then pulverized to obtain drug powder.
[0032] In the present invention, the Chinese medicine composition of rhubarb, kansui and donkey-hide gelatin is selected and soaked in water. The water added in the present invention is preferably ultrapure water; the mass volume ratio of the Chinese medicine composition to water is preferably 1g: (15-25) mL, further preferably 1g: (16-22) mL, and further preferably 1g: 18 mL; the soaking time is preferably 20-40 min, further preferably 25-35 min, and further preferably 30 min.
[0033] In the present invention, after soaking, the Chinese medicine composition and the water used to soak the composition are directly decocted, and the decoction method is preferably to first heat to boiling with high heat, and then adjust to slow heat to continue decocting. The time of slow heat decoction in the present invention is preferably 45-70min / time, further preferably 50-65min / time, and further preferably 60min / time; the number of decoctions is preferably 2-3 times, and further preferably 2 times. Preferably, stirring is performed during the slow heat decoction in the present invention; filtering is performed after the decoction is completed, the medicinal residue is separated, the filtrate is collected, and then the filtrate is combined. In the present invention, the second decoction is preferably slow heat decoction; the amount of water added during the second decoction is preferably 6 / 24-12 / 24 times the amount of water added during soaking, further preferably 7 / 24-10 / 24 times, and further preferably 8 / 24 times. In the present invention, the purpose of the second decoction is to precipitate the remaining effective ingredients of the Chinese medicine composition to the maximum extent.
[0034] In the present invention, the filtrate is concentrated to obtain a medicinal solution, and the degree of concentration is preferably a volume ratio of the medicinal solution to the amount of water added during immersion of 1:(8-14), further preferably 1:(9-12), and further preferably 1:10.
[0035] In the present invention, the obtained medicinal solution is subjected to a centrifugal operation, and the centrifugal operation is preferably performed using a low-temperature high-speed centrifuge. The centrifugal time is preferably 15-30 min, further preferably 20-25 min, and further preferably 22 min; the centrifugal speed is preferably 2000-4000 rpm, further preferably 2500-3500 rpm, and further preferably 2800 rpm; the low temperature is preferably set to -4°C.
[0036] In the present invention, vacuum drying is preferably performed after centrifugation, and the drying time is preferably 20-28 hours, more preferably 21-25 hours, and even more preferably 22 hours.
[0037] In the present invention, after vacuum drying, freeze drying is performed to obtain a crystalline powder, and the freeze drying temperature is preferably -(18-25)°C, more preferably -(19-22)°C, and more preferably -20°C; the freeze drying time is preferably 10-15h, more preferably 11-13h, and more preferably 12h. In the present invention, the obtained crystalline powder is crushed to obtain the medicinal powder.
[0038] The present invention also provides a rhubarb and kansui preparation comprising the traditional Chinese medicine composition. In the present invention, the preparation is a liquid preparation.
[0039] In the present invention, the preparation method of the rhubarb and kansui preparation comprises the following steps: mixing the above-prepared Chinese medicine composition powder and the solution in a mass volume ratio of 1 g: (0.2-0.3) mL, and filtering. The solution in the present invention is preferably RPMI-1640 culture medium; the mass volume ratio of the mixture is further preferably 1 g: (0.22-0.28) mL, and further preferably 1 g: 0.25 mL. The filtration in the present invention is preferably carried out using a bacterial filter membrane, and the specification of the filter membrane is preferably 0.20-0.25 μm, further preferably 0.21-0.24 μm, and further preferably 0.22 μm. The bacterial filter membrane in the present invention is purchased from Merck Millipore, USA.
[0040] The present invention also provides the use of the rhubarb and kansui preparation in preparing a medicine for treating TgAb-damaged human thyroid follicular cells.
[0041] In the present invention, the use concentration of the rhubarb and kansui preparation is preferably 300-600 μg / mL, further preferably 350-450 μg / mL, and further preferably 400 μg / mL.
[0042] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0043] Example 1
[0044] A traditional Chinese medicine composition comprises 14 parts of rhubarb, 4 parts of kansui and 12 parts of donkey-hide gelatin.
[0045] The preparation method of the above Chinese medicine composition:
[0046] (1) adding ultrapure water at a mass volume ratio of 1 g:18 mL to the above-mentioned traditional Chinese medicine composition, soaking for 30 minutes, then heating to boiling over high heat, then adjusting to low heat and continuing to decoct for 60 minutes, filtering, separating the medicinal residues, and collecting the filtrate; adding ultrapure water 1 / 3 times the amount of water added during soaking to the medicinal residues for secondary decoction, after the secondary decoction for 60 minutes, filtering again, collecting the filtrate, and combining the filtrate; and then concentrating to a volume of 1 / 10 of the volume of the water added during soaking, thereby obtaining a medicinal solution;
[0047] (2) The obtained drug solution was centrifuged at 2800 rpm for 22 min, then vacuum dried for 22 h, covered with plastic wrap, and freeze-dried at -20°C for 12 h to obtain crystalline powder, which was crushed to obtain the product.
[0048] Example 2
[0049] A traditional Chinese medicine composition comprises 10 parts of rhubarb, 2 parts of kansui and 10 parts of donkey-hide gelatin.
[0050] The preparation method of the above Chinese medicine composition:
[0051] (1) adding ultrapure water at a mass volume ratio of 1 g: 15 mL to the above-mentioned traditional Chinese medicine composition, soaking for 20 minutes, then heating to boiling over high heat, then adjusting to low heat and continuing to decoct for 45 minutes, filtering, separating the residues, and collecting the filtrate; adding ultrapure water 1 / 4 times the amount of water added during soaking to the residues for secondary decoction, after the secondary decoction for 50 minutes, filtering again, collecting the filtrate, and combining the filtrate; and then concentrating to a volume of 1 / 8 of the volume of the water added during soaking, thereby obtaining a medicinal solution;
[0052] (2) The obtained drug solution was centrifuged at 2000 rpm for 15 min, then vacuum dried for 20 h, covered with plastic wrap, and freeze-dried at -18°C for 10 h to obtain crystalline powder, which was crushed to obtain the product.
[0053] Example 3
[0054] A traditional Chinese medicine composition comprises 18 parts of rhubarb, 6 parts of kansui and 15 parts of donkey-hide gelatin.
[0055] The preparation method of the above Chinese medicine composition:
[0056] (1) adding ultrapure water at a mass volume ratio of 1 g: 25 mL to the above-mentioned traditional Chinese medicine composition, soaking for 40 minutes, then heating to boiling over high heat, then adjusting to low heat and continuing to decoct for 70 minutes, filtering, separating the medicinal residues, and collecting the filtrate; adding ultrapure water 1 / 2 times the amount of water added during soaking to the medicinal residues for secondary decoction, after the secondary decoction for 65 minutes, filtering again, collecting the filtrate, and combining the filtrate; and then concentrating to a volume of 1 / 12 of the volume of the water added during soaking, to obtain a medicinal solution;
[0057] (2) The obtained drug solution was centrifuged at 4000 rpm for 30 min, then vacuum dried for 25 h, covered with plastic wrap, and freeze-dried at -22°C for 13 h to obtain crystalline powder, which was crushed to obtain the product.
[0058] Example 4
[0059] A rhubarb and kansui preparation comprising the Chinese medicine composition of Example 1: the Chinese medicine composition powder prepared in Example 1 is mixed with RPMI-1640 culture medium at a mass volume ratio of 1 g: 0.25 mL. After mixing evenly, the mixture is filtered through a bacterial filter membrane with a pore size of 0.22 μm to obtain the product.
[0060] Example 5
[0061] A rhubarb and kansui preparation comprising the Chinese medicine composition of Example 1: the Chinese medicine composition powder prepared in Example 1 is mixed with RPMI-1640 culture medium at a mass volume ratio of 1 g: 0.22 mL. After mixing evenly, the mixture is filtered through a bacterial filter membrane with a pore size of 0.22 μm to obtain the product.
[0062] Example 6
[0063] A rhubarb and kansui preparation comprising the Chinese medicine composition of Example 1: the Chinese medicine composition powder prepared in Example 1 is mixed with RPMI-1640 culture medium at a mass volume ratio of 1 g: 0.28 mL. After mixing evenly, the mixture is filtered through a bacterial filter membrane with a pore size of 0.22 μm to obtain the product.
[0064] Test Example 1
[0065] 1. Cell culture
[0066] Quickly take out the cryovial of Nthy-ori3-1 cells (purchased from JENNIO Biological Technology) from the liquid nitrogen tank, put the cryovial containing 1 mL of cell suspension into a 37°C water bath to thaw, wipe the surface of the cryovial with alcohol and move it into the clean bench, add 4 mL of RPMI-1640 medium (purchased from Gibco, USA) and mix it, centrifuge at 1000 rpm for 5 min, discard the supernatant, and then blow it with 9 mL of RPMI-1640 medium, add 1 mL of FBS (purchased from Gibco, USA), move all the cell suspensions into a cell culture dish, place it in a 37°C constant temperature cell culture incubator, change the medium every other day, and observe the cell growth at any time. After 1 day of cell recovery culture, observe the cell growth and change the medium. Place the cell culture dish in a clean bench and shake it crosswise to remove the cells that were not firmly attached to the wall. Aspirate the original culture medium, add 10 mL of serum-free RPMI-1640 culture medium twice in equal amounts, shake and wash, add 10 mL of complete culture medium containing 15% FBS, and place in an incubator for culture.
[0067] (II) MTT assay
[0068] The rhubarb and kansui preparation prepared in Example 4 was diluted in multiples with a concentration of 400 μg / mL as the maximum value, and the concentration gradients were 400 μg / mL, 200 μg / mL, 100 μg / mL, 50 μg / mL, 25 μg / mL and 12.5 μg / mL for later use.
[0069] Nthy-ori3-1 cells were observed under an inverted microscope. When the cell morphology was good and the density reached about 80%, the cells in the logarithmic growth phase were subcultured. After counting the cells, 200 μL of 1×10 4 The cells were inoculated at a concentration of 100 μL / well into a 6-well plate and cultured in a cell culture incubator for 24 h. The supernatant was then removed and the plate was washed twice with 210 μL / well PBS. The supernatant in each well was then removed (to avoid interference of the original low-level antibodies in the experiment).
[0070] The 6-well plate was divided into 4 groups from left to right: blank control group (RPMI-1640 culture medium), model control group (RPMI-1640 culture medium + TgAb), model administration group (RPMI-1640 culture medium + TgAb + Example 4 preparation), blank administration group (RPMI-1640 culture medium + Example 4 preparation), and 3 rows of duplicate wells were set in each group. Among them, 100 μL of serum-free RPMI-1640 culture medium was added to each well of the blank control group and the blank administration group, and at the same time, 100 μL of TgAb working solution with a concentration of 8 ng / mL was added to each well of the model control group and the model administration group. After the working solution of each group fully acted on the cells for 15 minutes, 100 μL of serum-free RPMI-1640 culture medium was added to each well of the blank control group and the model control group, and at the same time, 100 μL of Example 4 preparation with a concentration of 100 μg / mL was added to each well of the model administration group and the blank administration group, and the cell culture incubator was placed to continue culturing. After culturing for 24 hours, take out the 6-well plate and observe it under a microscope, transfer it to a clean bench and discard the supernatant, add 100 μL of 10% MTT working solution (purchased from Sigma, USA) to each well, continue incubation in the incubator for 3.5-4 hours, discard the MTT solution, add 150 μL of DMSO solution (purchased from Beijing Solebow Technology Co., Ltd.) to each well, move it to a horizontal shaker and shake it for 20 minutes to completely dissolve the crystal violet, and measure the absorbance OD value at 570 nm with an enzyme marker. Repeat the experiment 3 times. Calculate the cell protection rate of each group under the action of the preparation of Example 4, and use GraphPadPrism software to make a drug dose-effect concentration curve.
[0071] Drug protection rate of blank administration group = (blank administration group OD value - blank control group OD value) / blank control group OD value × 100%
[0072] Drug protection rate of model drug administration group = (OD value of model drug administration group - OD value of model control group) / OD value of model control group × 100%
[0073] Net protection rate of the model drug administration group = drug protection rate of the model group - drug protection rate of the blank group
[0074] Table 1 Protection rate of different groups of preparations on normal or model cells
[0075]
[0076] According to Table 1 and Figure 1 As shown, compared with the blank administration group, the cell activity protection effect of the model administration group is more obvious, that is, the rhubarb and kansui preparation prepared in Example 4 of the present invention can alleviate the proliferation damage of thyroid follicular cells induced by TgAb.
[0077] Test Example 2 Cell scratch test
[0078] Use a marker to mark two parallel straight lines of moderate width on the bottom of each well of the 6-well plate in advance. Normally cultured Nthy-ori3-1 cells were routinely operated according to the cell passaging steps, and 1×10 6 Cells were cultured for 24h to ensure that the cells covered about 90% of the bottom of the dish. A 200μL gun tip was used to scratch each well. The gun tip was evenly applied to make it perpendicular to the thin line marked on the bottom of the dish. Two scratches were made in each well. After scratching, PBS was washed twice to wash away the cells that fell off after mechanical damage, and then PBS was removed. The model control group was added with 500μL of serum-free RPMI-1640 medium containing TgAb at a concentration of 8ng / mL, and 500μL of serum-free RPMI-1640 medium was added after the antibody acted for 15min. The model administration group was also first added with 500μL of serum-free RPMI-1640 medium containing TgAb at a concentration of 8ng / mL, and 500μL of RPMI-1640 medium containing the rhubarb and kansui preparation of Example 4 at a concentration of 400μg / mL was added after 15min for culture. The cell growth was observed and photographed at 0 and 24 h, respectively, and the same scratch site was taken at each time point as much as possible. Finally, Image J software was used for analysis and calculation.
[0079] Cell migration rate = (initial area - 24h area) / initial area × 100%.
[0080] according to Figure 2 and Figure 3 It can be obtained that the scratch healing rate of the model control group was 36.49±2.09%, and the scratch healing rate of the model medication group was 20.54±2.47%, indicating that the rhubarb and kansui preparation prepared in Example 4 of the present invention can alleviate the migration of damaged thyroid follicular cells, accelerate the disappearance of inflammation, and facilitate the development of tissue regeneration and repair.
[0081] Experimental Example 3 Observation of cell morphology using an inverted phase contrast microscope
[0082] Nthy-ori3-1 cells in the logarithmic growth phase were digested with 0.25% EDTA-containing trypsin solution, and after counting the cells, they were diluted to a cell density of 5×10 5After the cell suspension of cells / mL was inoculated in a 6-well plate, the supernatant in the well plate was sucked off and washed twice with PBS solution. Four groups of blank control group, model control group, model administration group and blank administration group were set. 500 μL of serum-free RPMI-1640 medium was added to each well of the blank control group and the blank administration group, while 500 μL of TgAb working solution at a concentration of 8 ng / mL was added to each well of the model control group and the model administration group. After the action time was 15 min, 500 μL of serum-free RPMI-1640 medium was continued to be added to each well of the blank control group and the model control group, while 500 μL of RPMI-1640 medium containing the rhubarb and kansui preparation of Example 4 was added to each well of the blank administration group and the model administration group at a concentration of 400 μg / mL. After the 6-well plate was placed in a constant temperature incubator and continued to be cultured for 24 hours, it was transferred to an inverted phase contrast microscope to observe the morphological changes of each group of cells and magnified to 200 times for photographing and recording.
[0083] Apoptosis of thyroid cells has an atypical thyroid follicle morphology, and the differences in each stage can be obtained from morphological observation: first, the cells shrink, the connections disappear, and they detach from the adjacent cells; then the cell permeability changes, the mitochondrial membrane potential decreases, cytochrome C is released into the cytoplasm, the nucleoplasm condenses, the nuclear membrane and nucleolus are broken, and the DNA is fragmented; the cell membrane has vesicles (blistering), and the phosphatidylserine on the inner side of the membrane is everted and moved to the cell membrane surface, at this time the cell membrane structure is still intact; finally, apoptotic bodies are formed, no contents overflow, and the cytoskeleton disintegrates.
[0084] The results are as follows Figure 4 As shown in the figure, compared with the blank control group, the epithelial cell morphology in the blank administration group did not change significantly, the cell boundaries were clear, the cytoplasm was transparent; the intercellular space was relatively wide, but the edges were clear, and the growth was good. Compared with the model control group, there were more cell vacuoles in the model administration group; in terms of cell morphology, the cells were more stretched and irregular in shape. Compared with the blank administration group, the cell boundaries in the model administration group were unclear, the edges were blurred, the cytoplasm was less, there were bubble-like cell structure protrusions, and cell fragments were visible.
[0085] Experimental Example 4 Flow Cytometry
[0086] After observing the status of Nthy-ori3-1 cells under a microscope, the cell subculture step was performed, the cells were centrifuged and counted, and 1 mL of the medium containing 1×10 6cells were added to each well of a 6-well plate, a small amount of fetal bovine serum was added to each well, and the 6-well plate was gently shaken, placed in a constant temperature incubator for 24 hours, and then the cells were observed, and then shaken and washed with PBS, and then three groups of blank control group, model control group and model administration group were set up. While 500 μL of serum-free RPMI-1640 culture medium was added to each well of the blank control group, 500 μL of TgAb working solution at a concentration of 8 ng / mL was added to each well of the model control group and the model administration group. After the action time was 15 minutes, 500 μL of serum-free RPMI-1640 culture medium was continued to be added to each well of the blank control group and the model control group, and 500 μL of RPMI-1640 culture medium containing the rhubarb and kansui preparation of Example 4 was added to each well of the model administration group at a concentration of 400 μg / mL.
[0087] After the 6-well plate was transferred to an incubator and cultured for 24 h, the cells were washed once with PBS according to the instructions of the Annexin V-FITC apoptosis detection kit (purchased from Hangzhou Lianke Biotechnology Co., Ltd.), and the cells were digested with an appropriate amount of EDTA-free trypsin digestion solution (EDTA may affect the binding of Annexin V to phosphatidylserine). The digestion was terminated, the cells were gently blown and centrifuged at 2000 rpm for 5 min to collect the cells, the supernatant was discarded, and the cells were resuspended twice in 4 mL of precooled PBS. The cells were counted and collected (1-10)×10 5 cells, centrifuge again and discard the supernatant, resuspend each group of cells in 500 μL of 1×Binding Buffer into flow tubes, add 5 μL of AnnexinV-FITC dye to each tube, store at room temperature in the dark for 5 minutes after resuspending, add 10 μL of PI to each tube, gently flick to mix, incubate at room temperature in the dark for 5 minutes, and detect cell apoptosis rate by flow cytometer within 1 hour. Finally, use Flow Jo software to analyze the apoptosis results.
[0088] Table 2 Cell activity and apoptosis in different groups
[0089] Group Cell activity rate (%) Cell apoptosis rate (%) Blank control group 84.7 11.35 Model control group 13.6 36.01 Model drug group 25.5 32.02
[0090] The results are shown in Table 2 and Figure 5 As shown, compared with the blank control group, the cell apoptosis rate in the model control group was significantly increased, indicating that TgAb did induce excessive apoptosis of thyroid follicular cells; the cell apoptosis rate in the model medication group was relatively low, indicating that after medication intervention, the number of living cells can be increased and the occurrence of cell apoptosis can be alleviated.
[0091] Test Example 5 Enzyme-linked immunosorbent assay
[0092] After Nthy-ori3-1 cells were subcultured according to the procedure, 1 mL of 1×10 6cells were added to each well of a 6-well plate, a small amount of fetal bovine serum was added to each well, and the 6-well plate was gently shaken, placed in a constant temperature incubator for 24 hours, and then the cells were observed, and then shaken and washed with PBS, and then three groups of blank control group, model control group and model administration group were set up. While 500 μL of serum-free RPMI-1640 culture medium was added to each well of the blank control group, 500 μL of TgAb working solution at a concentration of 8 ng / mL was added to each well of the model control group and the model administration group. After the action time was 15 minutes, 500 μL of serum-free RPMI-1640 culture medium was continued to be added to each well of the blank control group and the model control group, and 500 μL of RPMI-1640 culture medium containing the rhubarb and kansui preparation of Example 4 was added to each well of the model administration group at a concentration of 400 μg / mL. Then transfer the 6-well plate to an incubator and culture for 24 hours. Take the cell supernatant and transfer it to 2 mL EP tubes. Centrifuge at 2500 rpm for 20 minutes at 4°C. Then pipette the supernatant into a new spare EP tube as a sample for subsequent experiments or store it in a -80°C refrigerator.
[0093] Before the experiment officially begins, place the ELISA kit at room temperature for 30 minutes. Then follow the instructions in the relevant manual to operate in accordance with the instructions. Use the corresponding detection reagents for human thyroxine (T4) and inflammatory factors (IL-6), and do not confuse them. Set up blank wells, standard wells, and sample wells to be tested, dilute and add concentrated washing solution and standard samples, and then (incubate and wash) add enzyme label reagent except blank wells, incubate and wash, add colorimetric reagent and mix, keep in dark at 37°C for 15 minutes, stop the reaction with stop solution, and finally adjust the blank well to zero. Within 15 minutes, quickly detect the absorbance OD value at a wavelength of 450nm. Then, according to the known concentration of the standard and the detected OD value, use Excel software to calculate the linear regression equation and calculate the sample concentration, and use GraphPad Prism8 software for statistical analysis. The results are shown in Table 3-4.
[0094] Table 3 T4 content in cell supernatant of different groups
[0095] Group T4 content (nmol / L) Blank control group 56.65±3.47 Model control group 27.2±1.87 Model drug group 41.47±0.55
[0096] Table 4 IL-6 content in cell supernatants of different groups
[0097]
[0098]
[0099] From Table 3-4 and Figure 6It can be seen that in terms of T4 content, the T4 content in the model administration group is higher than that in the model control group and lower than that in the blank control group; while the content of the inflammatory factor IL-6 in the model administration group is lower than that in the model control group. This indicates that the rhubarb and kansui preparation prepared in Example 4 of the present invention can effectively alleviate the inflammatory damage caused by overexpression of the inflammatory factor IL-6 in the thyroid follicular cell injury model and regulate the secretion level of T4.
[0100] According to the above embodiments and test examples, it can be seen that the composition obtained by scientifically combining the three components of rhubarb, kansui and donkey-hide gelatin selected by the present invention can alleviate the proliferation damage of thyroid follicular cells induced by TgAb; it can alleviate the migration of damaged thyroid follicular cells, accelerate the disappearance of inflammation, and facilitate the development of tissue regeneration and repair; it can also significantly reduce the scratch healing rate; it can also significantly alleviate the inflammatory damage caused by overexpression of the inflammatory factor IL-6 in the thyroid follicular cell injury model, and regulate the T4 secretion level.
[0101] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A Chinese medicine composition, characterized in that: The composition comprises the following components in parts by weight: 10-18 parts of rhubarb, 1-7 parts of kansui and 10-15 parts of donkey-hide gelatin.
2. A method for preparing the Chinese medicine composition according to claim 1, characterized in that: The steps include: (1) adding water to the traditional Chinese medicine composition at a mass volume ratio of 1 g: (15-25) mL for soaking, then decocting and concentrating to obtain a medicinal solution; (2) The drug solution is centrifuged, freeze-dried, and then pulverized to obtain drug powder.
3. The preparation method according to claim 2, characterized in that: The soaking time in step (1) is 20-40 minutes; The decoction time is 45-70 min / time, and the decoction frequency is 2-3 times.
4. The preparation method according to claim 2, characterized in that: The centrifugation time in step (2) is 15-30 min, and the centrifugation speed is 2000-4000 rpm.
5. A rhubarb and kansui preparation comprising the traditional Chinese medicine composition of claim 1 or the traditional Chinese medicine composition prepared by the preparation method of any one of claims 2 to 4.
6. The rhubarb and kansui preparation according to claim 5, characterized in that The preparation is a liquid preparation.
7. Use of the rhubarb and kansui preparation according to claim 5 in the preparation of a drug for treating human thyroid follicular cells damaged by TgAb.
8. The use according to claim 7, characterized in that: The use concentration of the rhubarb and kansui preparation is 300-600 μg / mL.
